COVID-19 Related Drug Shortage in U.S. Because China Supplies Most Ingredients
Story Highlights The FDA has reported its first drug shortage as a result of the COVID-19 outbreak in China. Many drug ingredients and finished drug products used in the U.S are sourced and manufactured in China. The possibility of potential drug shortages highlights the issue of how the U.S. is heavily reliant on China for […]
Adenovirus Based Coronavirus Vaccine Being Tested
Greffex, Inc., a privately-held, multinational genetic engineering company headquartered in Houston, Texas has announced that it has completed development of a vaccine for the COVID-19 coronavirus. The vaccine will now proceed to testing in laboratory animals under supervision by the U.S Food and Drug Administration (FDA) and regulatory agencies in China.1 Greffex Got $18.9M from […]
Doctors Avoid Hand Washing Despite Evidence It is Best Way to Reduce Infections
The U.S. Centers for Disease Control and Prevention (CDC) has been urging everyone to thoroughly and frequently wash their hands since reports of the coronavirus outbreak in China, highlighting the long recognized practice of hand washing as a tried and true infection control measure.1 A little known fact is that among all health care providers, […]
Is a Bill Requiring Your Children to Get Every CDC Recommended Vaccination Coming to Your State?
As vaccine-related bills are being introduced into state legislatures this month, a bill (HB1090) has been proposed in the Virginia legislature to require school children to receive every dose of all current and future vaccines added to the recommended childhood vaccine schedule by the Advisory Committee on Immunization Practices (ACIP) appointed by the U.S. Centers […]
Only One Percent of Vaccine Reactions Reported to VAERS
Story Highlights The Vaccine Adverse Event Reporting System (VAERS) was created by Congress in 1986 as part of the National Childhood Vaccine Injury Act. Although health care providers are required by federal law to report specific vaccine reactions to VAERS, less than one percent of adverse events following vaccination are reported. Doctors, medical workers, adult patients […]
Tamiflu on Track to Be an Over-The-Counter Drug
In July 2019, drug and French vaccine manufacturer Sanofi signed a deal with Roche Pharmaceuticals to obtain exclusive over-the-counter (OTC) rights for Tamiflu (oseltamivir), an antiviral drug licensed for the treatment of influenza infections. Genentech, a member of the Roche Group, currently sells Tamiflu in the United States only for prescription use.1 Tamiflu is a […]